Bradford D. Dahms
CIK 1787307 · Chief Financial Officer · last filed 2026-02-13
Bradford D. Dahms is a Chief Financial Officer who has filed 12 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for JBIO, was dated Feb 13, 2026. Across all open-market trades the lifetime net is +$30.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $580.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$580.1K
3
12
$30.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| JBIO | Chief Financial Officer | 37,813 | $15.34 | $580.1K | $0 | 2 | 2026-02-13 |
| Theseus Pharmaceuticals, Inc. (THRX) Delisted | President and CFO | 0 | $4.06 | $0 | $30.0K | 6 | 2024-02-14 |
| Cartesian Therapeutics, Inc. (SELB) Delisted | Chief Financial Officer | 38,000 | $0.88 | $33.5K | $0 | 4 | 2021-01-06 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-13 | JBIO | Grant (A) | +37,813 | $0 | EDGAR |
| 2025-07-14 | JBIO | Grant (A) | — | $0 | EDGAR |
| 2024-02-14 | Theseus Pharmaceuticals, Inc. (THRX) Delisted | Mixed | −8,150 | $0 | EDGAR |
| 2023-03-02 | Theseus Pharmaceuticals, Inc. (THRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-02-21 | Theseus Pharmaceuticals, Inc. (THRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-12-01 | Theseus Pharmaceuticals, Inc. (THRX) Delisted | Buy (P) | +1,502 | $10.0K | EDGAR |
| 2022-02-23 | Theseus Pharmaceuticals, Inc. (THRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-22 | Theseus Pharmaceuticals, Inc. (THRX) Delisted | Buy (P) | +1,970 | $20.0K | EDGAR |
| 2021-01-06 | Cartesian Therapeutics, Inc. (SELB) Delisted | Grant (A) | +38,000 | $0 | EDGAR |
| 2020-07-06 | Cartesian Therapeutics, Inc. (SELB) Delisted | Grant (A) | — | $0 | EDGAR |